S'abonner

Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry - 08/12/22

Doi : 10.1016/j.ahj.2022.10.002 
Adam J Nelson, MBBS, MBA, MPH, PhD a, b, , Taku Inohara, MD, PhD a, b, Sunil V. Rao, MD a, b, Lisa A. Kaltenbach, MS a, b, Daniel Wojdyla, PhD a, b, Tracy Y. Wang, MD, MHS, MSc a, b
a Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 
b Department of Cardiology, Keio University School of Medicine, Tokyo, Japan 

Reprint requests: Dr. Adam J. Nelson, MBBS, MBA, MPH, PhD, Duke Clinical Research Institute, Durham, NC 27713.Department of CardiologyCardiovascular Investigation UnitDuke Clinical Research InstituteRoyal Adelaide Hospital Port RoadAdelaideSA5000

Abstract

Background

Appropriate use criteria (AUC) have been developed to promote the rational use of percutaneous coronary intervention (PCI) among clinicians and to provide benchmarking feedback to hospitals. The original AUC were published in 2012 and subsequently updated in 2017 to reflect emerging, contemporary evidence however the degree to which the updated guidance re-classifies PCI appropriateness is unknown.

Methods

Elective PCI cases from March 1, 2018 until June 30, 2021 were identified from within the NCDR CathPCI database. PCI cases were classified as ‘appropriate,’ ‘uncertain’ or ‘inappropriate’ under 2012 AUC and ‘appropriate,’ ‘may be appropriate’ or ‘rarely appropriate’ under 2017 AUC; those with missing data elements were termed ‘not mappable.’ Groups that ‘remained appropriate’ (appropriate in both 2012 and 2017), ‘became non-appropriate’ (‘appropriate’ in 2012 but became either ‘may be appropriate’ or ‘rarely appropriate in 2017) and ‘became appropriate’ (‘appropriate’ in 2017 but were ‘uncertain’ or ‘inappropriate’ in 2012) were descriptively compared. Concordance was assessed by calculation of Cohen's Kappa.

Results

A total of 245,196 patients underwent elective PCI across 1669 centers. By 2012 AUC, 44% were classified ‘appropriate,’ 28% were ‘uncertain’ and 16% were ‘inappropriate’ compared with 2017 AUC which considered 34% ‘appropriate’, 56% may be ‘appropriate’ and 4% ‘rarely appropriate’. Overall fair agreement was observed with a Kappa statistic of 0.40 (95%CI 0.396-0.403). Compared with PCI that ‘remained appropriate’ under the 2017 AUC, PCI that ‘became non-appropriate’ in 2017 were more likely to be asymptomatic, less likely to be on anti-anginals and less likely to have complex lesions. Compared with PCI that ‘became non-appropriate’, PCI that ‘became appropriate’ had a higher proportion of atypical and non-anginal symptoms and were less likely to have had positive functional tests. Procedural related outcomes were similar across all groups. A total of 29 429 PCI (12.0%) were not mappable by 2012 AUC while 16 077 (6.6%) were not mappable by 2017 AUC.

Conclusions

In this contemporary analysis of patients undergoing PCI in the United States, only fair agreement between the 2012 and updated 2017 AUC was observed. While some of this reflects the intention of the updated guidance, the large proportion that were considered ‘maybe appropriate’ or who ‘became non-appropriate’ reflect the difficulties of documenting and implementing contemporary AUC guidance.

Le texte complet de cet article est disponible en PDF.

Abbreviations : ACC, AUC, LAD, LCx, MI, NCDR, PCI, RCA, SCAI


Plan


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 255

P. 117-124 - janvier 2023 Retour au numéro
Article précédent Article précédent
  • Race and outcomes after percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
  • Stephanie M Spehar, Milan Seth, Peter Henke, Khaldoon Alaswad, Theodore Schreiber, Aaron Berman, John Syrjamaki, Omar E. Ali, Yousef Bader, David Nerenz, Hitinder Gurm, Devraj Sukul
| Article suivant Article suivant
  • Days at home after transcatheter or surgical aortic valve replacement in high-risk patients
  • Mabel Chung, Neel M. Butala, Kamil F. Faridi, Zaid I. Almarzooq, Dingning Liu, Jiaman Xu, Yang Song, Suzanne J. Baron, Changyu Shen, Dhruv S. Kazi, Robert W. Yeh

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.